284 filings
Page 6 of 15
8-K
pmd6fhuqb3bmx
16 Apr 18
SELLAS Life Sciences Reports Corporate Highlights, Advancements for its Cancer Immunotherapy Pipeline and 2017 Financial Results
12:00am
8-K/A
0tn1qf2f
13 Apr 18
Financial Statements and Exhibits
12:00am
8-K
k3abo1s
10 Apr 18
Other Events
12:00am
8-K/A
ywb82s0vbb707d
2 Apr 18
Changes in Registrant's Certifying Accountant
12:00am
8-K
jz7ntuvchp421 j9r
19 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
nq1 unzbnmk
12 Mar 18
SELLAS Life Sciences Announces $10,700,000 Private Placement
12:00am
8-K
x557x8j5ivspbq0hkzmz
27 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
539b 5gz8wgvtzhos1
20 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
m9ymy
12 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
thlqx62wzemw
18 Jan 18
Departure of Directors or Certain Officers
12:00am
8-K/A
rfb7oi
11 Jan 18
Completion of Acquisition or Disposition of Assets
12:00am
8-K
xwahhzjvtqo 82rtk03
5 Jan 18
Galena Biopharma, Inc. Stockholders Approve Business Combination with SELLAS Life Sciences Group, Ltd; Board Sets Reverse Stock Split Ratio
12:00am
8-K
vk223idi2z3wq
14 Dec 17
Other Events
12:00am
8-K
kj3ujq 88fkrh
9 Nov 17
Galena Biopharma Reports Third Quarter 2017 Financial Results
12:00am
8-K
424yjgt4j5ep1i ea
18 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
c3dxp90q521skurors2
2 Oct 17
Other Events
12:00am
8-K
auyrm
29 Sep 17
Galena Biopharma Announces Completion of Enrollment in Two
12:00am
8-K
80ekf40jt8ya4prvfwsd
25 Sep 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
b7vqg
14 Sep 17
Regulation FD Disclosure
12:00am
8-K
bzphphyee 59dl
11 Sep 17
Galena Biopharma and BioVascular, Inc. Reaffirm GALE-401 Partnership
12:00am